Extension Study of Bomedemstat (IMG-7289) in Patients With Myeloproliferative Neoplasms
Conditions: Thrombocythemia, Essential; Primary Myelofibrosis Intervention: Drug: Bomedemstat Sponsor: Imago BioSciences,Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials